Skip to content

Diffusion Pharmaceuticals Receives December 11, 2012 FDA Orphan Drug Designation For What Indication ?

December 11, 2012

       Diffusion Pharmaceuticals announces on December 11, 2012, that the FDA has given Orphan Drug Designation (ODD) for a 1st-in-class drug, Trans Sodium Crocetinate (TSC), for the treatment of Metastatic Brain Cancer.

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: